Pharmaceutical Technology

JUNE 9, 2023

Biopharmaceutical company Novaliq has received approval from the US Food and Drug Administration (FDA) for VEVYE (cyclosporine ophthalmic solution) 0.1% It has been designed to address the unmet needs of patients and to provide quick action and well-tolerated dry eye drug therapy. to treat the signs and symptoms of dry eye disease.

Food and Drug Administration 98

Food and Drug Administration FDA Medical science Food 98

Clarivate

MARCH 8, 2023

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. Data lags can extend the duration of diagnostic studies substantially, ultimately delaying patient access to life-saving medications.

Patients 59

Patients Biopharma Medical science Electronics 59

European Pharmaceutical Review

DECEMBER 28, 2023

Following their introduction, these therapies have moved to early lines of treatment, but unfortunately, a significant number of patients are not cured with these approaches. As a result, when the patient’s lymphoma relapses after treatment with chemotherapy, BV and CPIs, there are no effective treatment alternatives for these patients.

Food and Drug Administration 84

Food and Drug Administration Patients Safety Medical science 84

PM360

NOVEMBER 29, 2022

Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. 1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade.

Medical science 95

Medical science Medical Customer Relationship Management Doctors 95

Medico Reach

AUGUST 1, 2022

The early-stage venture financing firm Canaan Partners focuses on game-changing innovations in information, digital technologies, and the medical sciences. Over the last 31 years, the firm has managed a highly diversified $5 billion fund that comprises some of the top names in technology and life sciences. Canaan Partners.

Biopharma 52

Biopharma Healthcare Healthcare Specialization 52

Contrarian Sales Techniques

DECEMBER 5, 2023

As treatments become more tailored to individual patients, sales reps must understand complex scientific concepts and communicate them effectively. You need to comprehend and convey how these products can truly make a difference in patients' lives. Another game-changer has been the shift towards personalized medicine.

Pharmaceutical Sales 52

Pharmaceutical Sales Training Sales Pharmaceutical 52

Pharmaceutical Technology

NOVEMBER 21, 2022

Manufacturing woes have affected both cell and gene-modified cell therapies in oncology recently, disadvantaging patients with multiple myeloma (MM) and melanoma. DELTA-1 is a Phase II single-arm trial in metastatic melanoma, evaluating the efficacy of ITIL-168 in patients who have progressed on previous therapy.

Manufacturing 59

Manufacturing Food and Drug Administration Medical science Patients 59